Isofol Medical AB Working Capital to Net Assets Ratio
Isofol Medical AB working capital to net assets ratio. Isofol Medical AB (ISOFOL) has a Working Capital to Net Assets ratio of 100.6% as of December 2025. Working capital of Skr108.48 Million (current assets of Skr129.40 Million minus current liabilities of Skr20.91 Million) is measured against net assets of Skr107.87 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check Isofol Medical AB tangible net worth ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Isofol Medical AB (2011–2025)
Working capital to net assets ratio of Isofol Medical AB from 2011 to 2025. This chart shows how Isofol Medical AB's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2011 to 2025. As of December 2025, the ratio stands at 100.6%, reflecting working capital of Skr108.48 Million against net assets of Skr107.87 Million SEK. See Isofol Medical AB liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
Isofol Medical AB Working Capital to Net Assets Ratio by Year (2011–2025)
Isofol Medical AB working capital to net assets ratio by year from 2011 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Isofol Medical AB from 2011 to 2025, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Isofol Medical AB (ISOFOL) total assets.
| Year | WC/NA Ratio | Working Capital (SEK) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 100.6% | Skr108.48 Million | Skr107.87 Million | Skr129.40 Million | Skr20.91 Million | ▼ -0.3 pp |
| 2024 | 100.8% | Skr78.59 Million | Skr77.94 Million | Skr98.42 Million | Skr19.82 Million | ▲ +0.1 pp |
| 2023 | 100.7% | Skr122.34 Million | Skr121.43 Million | Skr140.59 Million | Skr18.25 Million | ▲ +0.5 pp |
| 2022 | 100.3% | Skr158.91 Million | Skr158.48 Million | Skr209.45 Million | Skr50.54 Million | ▲ +2.4 pp |
| 2021 | 97.9% | Skr311.59 Million | Skr318.23 Million | Skr394.61 Million | Skr83.02 Million | ▲ +8.2 pp |
| 2020 | 89.7% | Skr59.72 Million | Skr66.57 Million | Skr139.84 Million | Skr80.12 Million | ▼ -3.9 pp |
| 2019 | 93.6% | Skr98.22 Million | Skr104.91 Million | Skr137.02 Million | Skr38.80 Million | ▼ -4.8 pp |
| 2018 | 98.5% | Skr260.92 Million | Skr265.01 Million | Skr284.46 Million | Skr23.54 Million | ▼ -1.4 pp |
| 2017 | 99.9% | Skr342.55 Million | Skr343.03 Million | Skr360.80 Million | Skr18.24 Million | ▲ +9.1 pp |
| 2016 | 90.8% | Skr5.54 Million | Skr6.10 Million | Skr22.33 Million | Skr16.79 Million | ▲ +37.7 pp |
| 2015 | 53.0% | Skr701.00K | Skr1.32 Million | Skr9.16 Million | Skr8.46 Million | ▼ -36.0 pp |
| 2011 | 89.0% | Skr7.02 Million | Skr7.89 Million | Skr9.51 Million | Skr2.49 Million | — |